IBD Leaderboard
Overview
IBD Leaderboard is Investor's Business Daily's premium stock watchlist service, applying the legendary CAN SLIM methodology developed by William O'Neil. CAN SLIM evaluates stocks on seven criteria — Current earnings, Annual earnings, New products/management/highs, Supply and demand, Leader or laggard, Institutional sponsorship, and Market direction — creating a systematic framework for growth stock selection that has been refined over decades. At $70/month, it's the institutional implementation of one of the most influential equity selection methodologies ever published.
How It Works
Leaderboard maintains a curated watchlist of stocks meeting CAN SLIM criteria, with each stock annotated with IBD's proprietary ratings: Composite Rating (1-99), EPS Rating, Relative Strength Rating, and Accumulation/Distribution Grade. When a stock is added to or removed from the Leaderboard, subscribers are notified.
The methodology is rigorous and well-documented. A stock must demonstrate strong current and annual earnings growth, be near new highs, show evidence of institutional accumulation, and exist in a favourable market environment (IBD's market outlook determines overall exposure level). This systematic approach reduces subjectivity while maintaining the qualitative element of chart pattern analysis.
The Market Pulse — IBD's assessment of overall market health (confirmed uptrend, uptrend under pressure, or correction) — is perhaps the most valuable component. It tells subscribers when to be fully invested, cautious, or defensive, providing market timing guidance that many stock-picking services lack.
Signal format is watchlist-style rather than specific entry/exit alerts. Stocks appear on the Leaderboard when they meet criteria; subscribers must determine their own entry timing, position sizing, and exits.
Performance Analysis
IBD's CAN SLIM methodology has the longest verified track record of any systematic stock selection approach in our rankings. William O'Neil's original research, published in the 1960s, demonstrated the characteristics common to the best-performing stocks before their major moves. The methodology has been continuously refined and documented since.
The Leaderboard's performance is published by IBD and shows strong results in trending markets. However, like all growth stock methodologies, it's cyclical — CAN SLIM excels during bull markets with clear sector leadership and struggles during bear markets and rotational environments.
Our 3.0 verified performance score reflects the published methodology track record as meaningful (decades of documented history) but not independently audited in the signal-service sense. IBD publishes model portfolios and Leaderboard results, but these aren't tracked by a third-party auditor.
Strengths
- CAN SLIM methodology is one of the most influential and longest-documented stock selection systems in existence
- IBD proprietary ratings (Composite, EPS, RS, A/D) provide systematic, objective stock evaluation
- Market Pulse timing indicator helps subscribers know when to be aggressive vs defensive — crucial timing tool
- Decades of published methodology refinement — continuously improved since the 1960s
- Affordable at $70/month compared to services that apply CAN SLIM-derived approaches
- Educational value builds subscribers' ability to evaluate stocks independently using the rating system
Weaknesses
- Watchlist format rather than specific entry/exit signals — subscribers must determine their own timing
- Growth stock methodology is cyclical — underperforms significantly during bear markets and sector rotations
- Published results are IBD-managed, not independently audited by a third party
- Signal clarity score is lower because Leaderboard additions aren't formatted as actionable alerts with stops/targets
- Risk management is conceptual (Market Pulse guidance) rather than specific (no stop losses on individual picks)
- Equities-only with no options, forex, futures, or crypto coverage
Pricing & Value
At $70/month (often discounted annually), IBD Leaderboard is reasonably priced for what it delivers — the full IBD rating system, CAN SLIM-qualified stock watchlist, and Market Pulse timing indicator. For comparison: Minervini's Private Access costs ~$417/month for a methodology directly influenced by CAN SLIM. Oliver Kell charges ~$167/month for related growth stock picks.
The educational value extends beyond the picks. IBD's rating system teaches subscribers to evaluate stocks systematically, building analytical skills over time.
How It Compares
Against Oliver Kell (#4) and Minervini (#5), IBD Leaderboard provides the systematic framework that both those traders adapted for their own championship-winning approaches. Leaderboard is cheaper and more systematic; Kell and Minervini provide personal discretionary overlay and championship verification. IBD is the foundation; they are the applications.
Against The Empirical Collective (#35), IBD is a growth-focused system while TEC applies broad factor analysis. Both are systematic; they target different types of equity opportunities.
The honest positioning: IBD Leaderboard is the most time-tested systematic growth stock methodology available at retail prices. It lacks the personal touch and championship verification of individual traders, but the decades of documented refinement provide institutional-grade intellectual backing.
Who Is This For?
Growth stock investors who want the definitive CAN SLIM implementation with decades of methodological backing. Best for self-directed traders who can translate Leaderboard additions into their own trade plans with appropriate timing, sizing, and risk management.
Not ideal for traders wanting specific entry/exit signals, options or forex traders, those who need hand-holding on timing and risk management, or investors who can't commit to monitoring Market Pulse conditions.
Our Verdict
IBD Leaderboard earns #36 for delivering the most time-tested systematic growth stock methodology available at a reasonable price. CAN SLIM's influence on modern growth stock trading is enormous — multiple championship winners in our top 5 cite O'Neil's work as foundational.
The ranking reflects format rather than quality. The watchlist approach scores lower on signal clarity than services providing specific alerts, and the lack of independent auditing limits the verification score. The methodology itself is arguably more proven than any other systematic approach in our rankings — it just needs subscriber effort to translate into trades.
For investors who want the intellectual foundation of growth stock selection backed by decades of evidence, IBD Leaderboard is essential reading. For traders wanting actionable alerts they can follow directly, the services ranked above provide clearer signal delivery.